Phase 0 study of new spectrum imaging endoscopy

Phase 0 study of new spectrum imaging endoscopy - Sie Phase 0

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004983

Enrollment

Registered

2011-02-01

Start date

2011-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected or early oropharynx, hypopharynx, esophagus, stomach or colon cancer

Interventions

Endoscopic diagnosis of new spectrum imaging endoscopy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) aged 20 or over 2) PS (ECOG) of 0 or 1 3) Written informed consent 4) Meet following A) or B) criteria A) Endoscopic examination for euplastic lesion of or pharynx, hypo pharynx, esophagus, stomach or colon is scheduled B) Meet all following criteria 4B-i) EMR or ESD for early stage cancer of or pharynx, hypo pharynx, esophagus, stomach or colon is scheduled 4B-ii) no prior surgery, chemotherapy or radiation for cancer in the target organ 4B-iii)sufficient organ function

Exclusion criteria

Exclusion criteria: 1) impossible to discontinue anticoagulant or antiplatelet medication. 2) women during pregnancy or breast-feeding. 3) psychosis. 4) ileus, obstruction or perforation of the digestive tract 5) active bacterial or fungal infection. 6) history of myocardial infarction or unstable angina pectoris within three months. 7) uncontrollable hypertension.

Design outcomes

Primary

Measure	Time frame
Evaluation of new spectrum image	—

Secondary

Measure	Time frame
Adverse events Time needed for endoscopy	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026